Asian herbal medicine for atopic dermatitis: a systematic review
https://doi.org/10.4081/dr.2023.9727
Accepted: 4 July 2023
HTML: 12
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Asian herbal medicines have been known for decades, and some have been used to treat atopic dermatitis (AD). This chronic and persistent inflammatory skin condition causes severe morbidity and negatively impacts the quality of life. In numerous trials, traditional Chinese medicines have demonstrated clinical efficacy for AD. However, there is no well-documented summary of the wide variety of Asian herbal medicines used in treating AD. We aimed to systematically summarize the use of Asian herbal medicine in AD. An English-language literature search was performed in three electronic medical databases: PubMed, Cochrane Library, and EBSCOhost using keywords [(“atopic dermatitis” OR “atopic eczema”) AND (“traditional” OR “herbal”)] and limited to references published between January 2015 and December 2022. The literature included newborns, infants, children, adolescents, and adults. The review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension to determine the main criteria. The content and inclusiveness of the search were filtered using relevant terms (MeSH/Emtree), keywords, titles, and abstracts. Thirteen articles (12 randomized clinical trial + 1 clinical trial) reported a variety of herbal medicine compounds to treat AD with various efficacy. Most studies reported significant improvement when comparing the herbal medicine with a placebo, but only 1 study reported substantial improvement of SCORAD compared to corticosteroids. Asian herbal medicines have been studied and may be used as an alternative treatment in treating AD with fewer adverse effects. However, its role did not change the position of standard treatment in treating atopic dermatitis.
Tsakok T, Woolf R, Smith CH, et al. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol 2019;180:464-74.
Ali F, Vyas J, Finlay AY. Counting the burden: atopic dermatitis and health-related quality of life. Acta Derm Venereol 2020;100:330-40.
Olsson M, Bajpai R, Wee LWY, et al. The cost of childhood atopic dermatitis in a multi-ethnic Asian population: a cost-of-illness study. Br J Dermatol 2020;182:1245-52.
Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010;105:99-106.
Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124:1251-8.
Vinding GR, Zarchi K, Ibler KS, et al. Is adult atopic eczema more common than we think? - A population-based study in Danish adults. Acta Derm Venereol 2014;94:480-2.
Deckers IAG, McLean S, Linssen S, et al. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PloS One 2012;7:e39803.
Moniaga CS, Tominaga M, Takamori K. An altered skin and gut microbiota are involved in the modulation of itch in atopic dermatitis. Cells 2022;11:3930.
Tsai TF, Rajagopalan M, Chu CY, et al. Burden of atopic dermatitis in Asia. J Dermatol 2019;46:825-34.
Bhanegaonkar A, Horodniceanu EG, Ji X, et al. Burden of atopic dermatitis in Indonesia, Malaysia, and Singapore: estimates from a mathematical model. Value Health 2014;17:A778.
Chow S, Seow CS, Dizon MV, et al. A clinician’s reference guide for the management of atopic dermatitis in Asians. Asia Pac Allergy 2018;8.
Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol 2018; 178:768-75.
Manjelievskaia J, Boytsov N, Brouillette MA, et al. The direct and indirect costs of adult atopic dermatitis. J Manag Care Spec Pharm 2021;27:1416-25.
Albader SS, Alharbi AA, Alenezi RF, Alsaif FM. Dupilumab side effect in a patient with atopic dermatitis: a case report study. Biol Targets Ther 2019;13:79.
Cai X, Sun X, Liu L, et al. Efficacy and safety of Chinese herbal medicine for atopic dermatitis: Evidence from eight high quality randomized placebo-controlled trials. Front Pharmacol 2022;13.
Chew YL, Khor MA, Xu Z, et al. Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: food ingredients as complementary and alternative therapies for atopic dermatitis-a comprehensive review. Molecules 2022;27:5475.
Meysami M, Hashempur MH, Kamalinejad M, Emtiazy M. Efficacy of short term topical malva sylvestris l. cream in pediatric patients with atopic dermatitis: a randomized doubleblind placebo-controlled clinical trial. Endocr Metab Immune Disord - Drug Targets 2021;21:1673-8.
Abbasi S, Kamalinejad M, Babaie D, et al. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): a randomized, placebo-controlled clinical trial. Complement Ther Med 2017;35:85-91.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005;8:19-32.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021;10:1-11.
Higgins JPT, Altman DG, Sterne JAC, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8 Assessing risk of bias in included studies. Available from: https://handbook-5-1.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.htm [cited 2023 Jan 10]
Chishti MA, Mohi-Ud-Din E, Usmanghani K, et al. Comparative clinical efficacy and safety of coded herbal medicine Dermovix in the management of patients with atopic dermatitis versus allopathic medicine. Pak J Pharm Sci 2015;28:1655-63.
Yen CY, Hsieh CL. Therapeutic effect of Tzu-Yun ointment on patients with atopic dermatitis: a preliminary, randomized, controlled, open-label study. J Altern Complement Med NYN 2016;22:237-43.
Liu J, Mo X, Wu D, et al. Efficacy of a Chinese herbal medicine for the treatment of atopic dermatitis: a randomised controlled study. Complement Ther Med 2015;23:644-51.
Lin YK, Chang SH, Yang CYet al. Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial. J Ethnopharmacol 2020;250:112477.
Mehrbani M, Choopani R, Fekri A, et al. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: a randomized, double-blind, placebo- controlled clinical trial. J Ethnopharmacol 2015;172:325-32.
Iraji F, Makhmalzadeh BS, Abedini M, et al. Effect of herbal cream containing Fumaria officinalis and silymarin for treatment of eczema: a randomized double-blind controlled clinical trial. Avicenna J Phytomed 2022;12:155-62.
Ahn JH, Yun Y, Kim MH, et al. Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: a pilot randomized, double-blind, placebo-controlled study. Complement Ther Med 2018;40:22-8.
Gu SX, Mo X, Zhang AL, et al. A Chinese herbal medicine preparation (Pei Tu Qing Xin) for children with moderate-to-severe atopic eczema: a pilot randomized controlled trial. Br J Dermatol- 2018;179:1404-5.
Lee JH, Jo EH, Jung JY, et al. Efficacy and safety of Soshihotang in atopic dermatitis patients with gastrointestinal disorders: a double-blinded, randomized, and placebo-controlled clinical trial. J Ethnopharmacol 2021;274:114006.
Winayanuwattikun W, Varothai S, Tuchinda P, Kulthanan K. A double-blinded, randomized, split-side, vehicle-controlled study of the efficacy of cleanser containing Acanthus ebracteatus Vahl., Suregada multiflora, and Acacia concinna in patients with atopic dermatitis: A pilot study. Asian Pac J Allergy Immunol 2021. Available from: http://apjai-journal.org/wp-content/uploads/2020/10/AP-050519-0554.pdf
Ma T, Chai Y, Li S, et al. Efficacy and safety of Qinzhuliangxue decoction for treating atopic eczema: a randomized controlled trial. Ann Palliat Med 2020;9:870-82.
Thandar Y, Gray A, Botha J, Mosam A. Topical herbal medicines for atopic eczema: a systematic review of randomized controlled trials. Br J Dermatol 2017;176:330-43.
Sharma V, Agrawal RC. Glycyrrhiza glabra-a plant for the future. Mintage J Pharm Med Sci 2013;2:15-20.
Wang C, Chen L, Xu C, et al. A comprehensive review for phytochemical, pharmacological, and biosynthesis studies on Glycyrrhiza spp. Am J Chin Med 2020;48:17-45.
Bhattacharjee S, Bhattacharjee A, Majumder S, et al. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. J Antimicrob Chemother 2012;67:1905-14.
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
